Complete response to anti-PD-L1 antibody in a metastatic bladder cancer associated with novel MSH4 mutation and microsatellite instability is a research paper published in Journal for ImmunoTherapy of Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 60 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P30CA016056
National Cancer Institute
Grant: U24CA232979
National Center for Research Resources
Grant: S10OD019977
National Institutes of Health
Grant: 5P30CA016056-40
Roswell Park Cancer Institute Cancer Center Support Grant
National Institutes of Health
Grant: 1S10OD019977-01
Dako Omnis Autostainer for Screening Tumor Tissues with Immunohistochemistry
National Institutes of Health
Grant: 3U24CA232979-01S1
Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 2 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 6 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 6 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 7 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 7 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 8 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 8 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 9 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 9 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 10 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 10 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 11 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 11 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 12 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 12 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 13 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 13 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 14 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Additional file 14 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer